Concord Wealth Partners Embecta Corp. Transaction History

Concord Wealth Partners

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Apr 30, 2024	BUY	$15.0 - $22.17 $15 - $22	1 New	1 $0
Q3 2023 Oct 25, 2023	SELL	$15.0 - $22.17 $735 - $1,086	-49 Reduced 98.0%	1 $0
Q2 2023 Aug 07, 2023	BUY	$21.6 - $30.69 $21 - $30	1 Added 2.04%	50 $1,000
Q4 2022 Jan 27, 2023	BUY	$25.29 - $35.48 $1,239 - $1,738	49 New	49 $1,000
Q2 2022 Aug 04, 2022	BUY	$24.78 - $33.36 $1,982 - $2,668	80 New	80 $2,000

397

52.9M

215K

83.3K

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $819M
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

Get notified when there are updates to the investment portfolio of Concord Wealth Partners, based on Form 13F filings with the SEC.

Stay updated on Concord Wealth Partners with notifications on news.